News
Sports
Life
Opinion
Business
Advertise
Obituaries
eNewspaper
Legals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
DaVita HealthCare Partner
(NY:
DVA
)
164.11
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about DaVita HealthCare Partner
< Previous
1
2
3
4
5
6
7
Next >
Why Dialysis Stocks DaVita, Fresenius Soared On Novo's Ozempic News
March 05, 2024
Novo Nordisk tested its diabetes and weight-loss drug in patients with chronic kidney disease.
Via
Investor's Business Daily
3 Cheap Stocks to Buy Now for Fast Gains
February 22, 2024
Dive into the world of investing with cheap stocks DaVita, Altria, and StoneCo as they show potential growth.
Via
InvestorPlace
Dialysis Player Fresenius Medical's Q4 Sales Hold Steady: Details
February 20, 2024
Fresenius Medical Care Q4 2023 revenue: €4.9 billion. Patient volume growth is expected at 0.5%-2% in 2024.
Via
Benzinga
DaVita Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
February 20, 2024
Via
Benzinga
3 Top-Rated Stocks To Buy After Comfortably Surpassing Earnings Expectations
February 16, 2024
This week’s earnings lineup has featured several top-rated stocks that have added to this optimistic growth narrative and here are a few to consider
Via
Talk Markets
Why DaVita Stock Popped Today
February 14, 2024
The dialysis services company handily beat expectations with its latest quarter.
Via
The Motley Fool
DaVita: Q4 Earnings Insights
February 13, 2024
Via
Benzinga
DaVita Earnings Preview
February 12, 2024
Via
Benzinga
In-Depth Technical Analysis of DAVITA INC.
January 08, 2024
DAVITA INC (NYSE:DVA) has a strong technical rating of 9 out of 10, indicating a potential breakout.
Via
Chartmill
Bull of the Day: DaVita
December 30, 2023
Most anybody who works in healthcare is familiar with the company and its services which include 2,707 outpatient centers in 46 states, as well as 351 centers in 11 countries worldwide.
Via
Talk Markets
Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday
February 14, 2024
U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
DaVita (DVA) Q4 2023 Earnings Call Transcript
February 13, 2024
DVA earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Time To Buy These High Growth Stocks As Earnings Approach
February 13, 2024
This week’s earnings lineup will be highlighted by several growth stocks with none standing out more than Airbnb and DaVita
Via
Talk Markets
Meet the Most Ridiculously Cheap Stock in Warren Buffett's Berkshire Hathaway Portfolio
February 12, 2024
This stock isn't cheap because it's performed poorly over the past 12 months.
Via
The Motley Fool
DaVita: Q3 Earnings Insights
November 07, 2023
Via
Benzinga
Earnings Scheduled For February 13, 2024
February 13, 2024
Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million.
Via
Benzinga
2 Best Warren Buffett Stocks to Buy for the Long Haul
February 09, 2024
You don't need to have millions of dollars to invest in quality businesses.
Via
The Motley Fool
Earn a 5.79% Dividend Yield from DaVita Stock Using This Hack
January 31, 2024
Via
Benzinga
Don't Overlook These Top Value Stocks In January It's Time To Buy
January 12, 2024
Investors searching for value will want to pay attention to a few top-rated stocks that are standing out among the finance and medical sectors
Via
Talk Markets
Healthcare Sector Stocks: Consistent Above-Average Growth And Income
December 18, 2023
The healthcare sector is full of many really good companies with consistent, long term, above-average growth rates and many that have good, consistent, long-term dividend records.
Via
Talk Markets
5 Undervalued Stocks In The S&P 500 ETF To Buy For 2024
December 11, 2023
After several twists and turns, the S&P 500 has hit a series of new 2023 highs lately, driven by the optimism that the Fed is done with interest rate hikes.
Via
Talk Markets
Topics
ETFs
Economy
Stocks
Exposures
Interest Rates
US Equities
Only Have $100? 3 No-Brainer Stocks to Buy Right Now
November 28, 2023
The stock market is such a well-oiled, wealth-generating machine that investors can start with just $100 to buy these no-brainer stocks.
Via
InvestorPlace
7 Healthcare Stocks That Are Poised to Become the Next Unicorns
November 09, 2023
Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
November 08, 2023
Via
Benzinga
DaVita (DVA) Q3 2023 Earnings Call Transcript
November 07, 2023
DVA earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
October 27, 2023
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.
Via
Investor's Business Daily
Buffett’s Bullish Bets: 3 Stocks Where Warren Has At Least a 25% Stake
October 24, 2023
A man who likes to make big bets on businesses, these Warren Buffett stocks are his biggest ones without actually owning the business.
Via
InvestorPlace
3 Stocks to Buy From the ‘Buy the Dip’ ETF
October 23, 2023
It’s a lot harder than it looks to buy the dip. Using artificial intelligence to do this makes these three stocks a buy.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Stock Market Rallies, Hits Resistance; Novo Nordisk, JPMorgan, Exxon In Focus: Weekly Review
October 13, 2023
The major indexes stalled at key levels amid weak breadth.
Via
Investor's Business Daily
Novo Nordisk's Kidney Outcomes Trial Has Broad Industry Implications
October 12, 2023
Novo Nordisk A/S (NYSE: NVO) shares got a boost this week after the drugmaker halted trials testing potential treatment for kidney failure on
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.